{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:46:47Z","timestamp":1768319207107,"version":"3.49.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sex differences may be presented in the clinical features or symptoms of schizophrenia patients but also affect the occurrence of hospital-acquired pneumonia (HAP). Modified electroconvulsive therapy (mECT) is a common treatment method for schizophrenia, used in combination with antipsychotics. This retrospective research explores the sex difference in HAP affecting patients with schizophrenia who have received mECT treatment during hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included schizophrenia inpatients treated with mECT and antipsychotics between January 2015 and April 2022. Blood-related and demographic data collected on admission were analyzed. Influencing factors of HAP in male and female groups were assessed separately.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 951 schizophrenia patients treated with mECT were enrolled in the study, including 375 males and 576 females, of which 62 patients experienced HAP during hospitalization. The risk period of HAP in these patients was found to be the first day after each mECT treatment and the first three sessions of mECT treatment. Statistically significant differences in the incidence of HAP were identified in male vs. female groups, with an incidence in men about 2.3 times higher than that in women (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Lower total cholesterol (<jats:italic>Z<\/jats:italic> = \u22122.147, <jats:italic>P<\/jats:italic> = 0.032) and the use of anti-parkinsonian drugs (\u03c7<jats:sup>2<\/jats:sup> = 17.973, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) were found to be independent risk factors of HAP in male patients, while lower lymphocyte count (<jats:italic>Z<\/jats:italic> = \u22122.408, <jats:italic>P<\/jats:italic> = 0.016), hypertension (\u03c7<jats:sup>2<\/jats:sup> = 9.096, <jats:italic>P<\/jats:italic> = 0.003), and use of sedative-hypnotic drugs (\u03c7<jats:sup>2<\/jats:sup> = 13.636, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) were identified in female patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Influencing factors of HAP in schizophrenia patients treated with mECT have gender differences. The first day after each mECT treatment and the first three sessions of mECT treatment were identified to have the greatest risk for HAP development. Therefore, it would be imperative to monitor clinical management and medications during this period according to these gender differences.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1127262","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:07:01Z","timestamp":1676394421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Sex differences in factors influencing hospital-acquired pneumonia in schizophrenia patients receiving modified electroconvulsive therapy"],"prefix":"10.3389","volume":"14","author":[{"given":"Mi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xincheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/S2045796017000270","article-title":"Symptom rating scales for schizophrenia and other primary psychotic disorders in ICD-11","volume":"27","author":"Keeley","year":"2018","journal-title":"Epidemiol Psychiatr Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","article-title":"Definition and description of schizophrenia in the DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global regional and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/ijerph19031862","article-title":"Disease-related risk factors for caregiver burden among family caregivers of persons with schizophrenia: a systematic review and meta-analysis","volume":"19","author":"Peng","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.schres.2022.01.051","article-title":"Healthcare costs and resource use associated with negative symptoms of schizophrenia: a systematic literature review","volume":"241","author":"Weber","year":"2022","journal-title":"Schizophr Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/070674379704200204","article-title":"Epidemiology of schizophrenia","volume":"42","author":"Hafner Han der Heiden","year":"1997","journal-title":"Can J Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.eplepsyres.2007.12.001","article-title":"Difference in age of onset of psychosis between epilepsy and schizophrenia","volume":"78","author":"Adachi","year":"2008","journal-title":"Epilepsy Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41537-021-00188-7","article-title":"The effect of sex on social cognition and functioning in schizophrenia","volume":"7","author":"Ferrer-Quintero","year":"2021","journal-title":"NPJ Schizophr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"867468","DOI":"10.3389\/fpsyg.2022.867468","article-title":"Sex differences in social cognition and association of social cognition and neurocognition in early course schizophrenia","volume":"13","author":"Kubota","year":"2022","journal-title":"Front Psychol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.psychres.2010.11.009","article-title":"Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives","volume":"188","author":"Torniainen","year":"2011","journal-title":"Psychiatry Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.psychres.2018.12.011","article-title":"Gender differences in correlates of cognition in first-episode psychosis","volume":"271","author":"Li","year":"2019","journal-title":"Psychiatry Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.jcp.0000185423.15891.02","article-title":"Sex differences in the subjective tolerability of antipsychotic drugs","volume":"25","author":"Barbui","year":"2005","journal-title":"J Clin Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.eurpsy.2008.10.005","article-title":"A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients","volume":"24","author":"Riedel","year":"2009","journal-title":"Eur Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1078390309350918","article-title":"Schizophrenia: women bear a disproportionate toll of antipsychotic side effects","volume":"16","author":"Seeman","year":"2010","journal-title":"J Am Psychiatr Nurses Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.comppsych.2008.03.004","article-title":"Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery","volume":"49","author":"Grossman","year":"2008","journal-title":"Compr Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biopsych.2021.03.020","article-title":"Sex differences in the human brain transcriptome of cases with schizophrenia","volume":"91","author":"Hoffman","year":"2022","journal-title":"Biol Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13293-022-00422-6","article-title":"Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders","volume":"13","author":"Shobeiri","year":"2022","journal-title":"Biol Sex Differ."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41386-020-0765-1","article-title":"Sex and strain differences in dynamic and static properties of the mesolimbic dopamine system","volume":"45","author":"Rivera-Garcia","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.schbul.a007128","article-title":"At issue: sex and gender in schizophrenia","volume":"30","author":"Lewine","year":"2004","journal-title":"Schizophr Bull."},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/schbul\/sbz037","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia","volume":"45","author":"Sinclair","year":"2019","journal-title":"Schizophr Bull."},{"key":"B22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/pcn.12855","article-title":"Clinical effectiveness and speed of response of electroconvulsive therapy in treatment-resistant schizophrenia","volume":"73","author":"Chan","year":"2019","journal-title":"Psychiatry Clin Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"103132","DOI":"10.1016\/j.ajp.2022.103132","article-title":"Efficacy and safety of maintenance electroconvulsive therapy (M-ECT) in treatment-resistant schizophrenia: a case series","volume":"73","author":"Purohith","year":"2022","journal-title":"Asian J Psychiatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr Scand."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.janh.2021.03.001","article-title":"The historical struggles of modified electroconvulsive therapy: how anesthesia came to the rescue","volume":"7","author":"Lava-Parmele","year":"2021","journal-title":"J Anesth Hist."},{"key":"B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bpa.2020.12.012","article-title":"Challenges and pitfalls in anesthesia for electroconvulsive therapy","volume":"35","author":"Soehle","year":"2021","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1213\/ANE.0000000000001873","article-title":"Individualized anesthetic management for patients undergoing electroconvulsive therapy: a review of current practice","volume":"124","author":"Bryson","year":"2017","journal-title":"Anesth Analg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00000539-199708000-00031","article-title":"Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol","volume":"85","author":"Kuehnert","year":"1997","journal-title":"Anesth Analg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/acps.12815","article-title":"Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sample","volume":"136","author":"Blumberger","year":"2017","journal-title":"Acta Psychiatr Scand."},{"key":"B30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S2213-2600(19)30140-7","article-title":"Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia","volume":"7","author":"Roquilly","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fpubh.2019.00221","article-title":"Incidence and related factors for hospital-acquired pneumonia among older bedridden patients in china: a hospital-based multicenter registry data based study","volume":"7","author":"Jiao","year":"2019","journal-title":"Front Public Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12890-021-01816-9","article-title":"Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Pulm Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2021.03.012","article-title":"Incidence and impact of hospital-acquired pneumonia: a portuguese nationwide four-year study","volume":"112","author":"Goncalves-Pereira","year":"2021","journal-title":"J Hosp Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e13762","DOI":"10.1111\/ijcp.13762","article-title":"Gender differences in incidence and in-hospital outcomes of community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in Spain","volume":"75","author":"Lopez-de-Andres","year":"2021","journal-title":"Int J Clin Pract."},{"key":"B35","doi-asserted-by":"publisher","first-page":"12645","DOI":"10.3390\/ijerph182312645","article-title":"Sex differences in hospital-acquired pneumonia among patients with type 2 diabetes mellitus patients: retrospective cohort study using hospital discharge data in Spain (2016-2019)","volume":"18","author":"Lopez-de-Andres","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e5453","DOI":"10.3390\/jcm10225453","article-title":"Assessing the impact of gender and COPD on the incidence and mortality of hospital-acquired pneumonia. A retrospective cohort study using the Spanish National Discharge Database (2016\u20132019)","volume":"10","author":"de-Miguel-Diez","year":"2021","journal-title":"J Clin Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3949\/ccjm.87a.19117","article-title":"Hospital-acquired and ventilator-associated pneumonia: diagnosis, management, and prevention","volume":"87","author":"Modi","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2022.06.014","article-title":"Risk factors for hospital-acquired pneumonia among inpatients with mental disorders in a large mental health center within a tertiary general hospital","author":"Han","year":"2022","journal-title":"Am J Infect Control."},{"key":"B39","doi-asserted-by":"publisher","first-page":"746791","DOI":"10.3389\/fpsyt.2021.746791","article-title":"Influencing factors of hospital-acquired pneumonia infection in the middle-aged and elderly patients with schizophrenia","volume":"12","author":"Yang","year":"2021","journal-title":"Front Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.30773\/pi.2020.0438","article-title":"Systematic review of the neural effect of electroconvulsive therapy in patients with schizophrenia: hippocampus and insula as the key regions of modulation","volume":"18","author":"Moon","year":"2021","journal-title":"Psychiatry Investig."},{"key":"B41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.brs.2017.01.578","article-title":"Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression","volume":"10","author":"Thomann","year":"2017","journal-title":"Brain Stimul."},{"key":"B42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-016-0688-2","article-title":"Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of gunn rat","volume":"13","author":"Limoa","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brs.2017.10.013","article-title":"Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review","volume":"11","author":"Yrondi","year":"2018","journal-title":"Brain Stimul."},{"key":"B44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0165-1781(01)00303-1","article-title":"Effect of electroconvulsive therapy on hematological parameters","volume":"104","author":"Chaturvedi","year":"2001","journal-title":"Psychiatry Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.22365\/jpsych.2021.027","article-title":"Do patients with schizophrenia have higher infection and mortality rates due to COVID-19? A systematic review","volume":"32","author":"Karaoulanis","year":"2021","journal-title":"Psychiatriki."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1071079","article-title":"Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients","author":"Yang","year":"2023","journal-title":"Front Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","journal-title":"Cell Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1192\/bjp.169.6.682","article-title":"Cholesterol and mental disorder","volume":"169","author":"Boston","year":"1996","journal-title":"Br J Psychiatry."},{"key":"B50","doi-asserted-by":"publisher","first-page":"32105","DOI":"10.1073\/pnas.2012197117","article-title":"Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion","volume":"117","author":"Zang","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"791267","DOI":"10.3389\/fimmu.2022.791267","article-title":"Coronavirus infection and cholesterol metabolism","volume":"13","author":"Dai","year":"2022","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"705916","DOI":"10.3389\/fpubh.2021.705916","article-title":"Cholesterol and triglyceride concentrations, COVID-19 severity, and mortality: a systematic review and meta-analysis with meta-regression","volume":"9","author":"Zinellu","year":"2021","journal-title":"Front Public Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ajem.2020.09.012","article-title":"Serum cholesterol as a predictor of mortality among the elderly patients with pneumonia in the emergency department","volume":"45","author":"Ko","year":"2021","journal-title":"Am J Emerg Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MED.0000000000000395","article-title":"Low cholesterol, impulsivity and violence revisited","volume":"25","author":"Tomson-Johanson","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B55","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.3390\/ijerph17176260","article-title":"The prevalence of anticholinergic drugs and correlation with pneumonia in elderly patients: a population-based study in Taiwan","volume":"17","author":"Lee","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3238\/arztebl.2016.0799","article-title":"Antiviral medications in seasonal and pandemic influenza","volume":"113","author":"Lehnert","year":"2016","journal-title":"Dtsch Arztebl Int."},{"key":"B57","first-page":"102","article-title":"Mechanism and adverse effects of COVID-19 drugs: a basic review","volume":"13","author":"Mohammad Zadeh","year":"2021","journal-title":"Int J Physiol Pathophysiol Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.yct.0000263252.75926.98","article-title":"Blood pressure before and after electroconvulsive therapy in hypertensive and nonhypertensive patients","volume":"23","author":"Albin","year":"2007","journal-title":"J ECT."},{"key":"B59","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41440-020-0485-2","article-title":"COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study","volume":"43","author":"Huang","year":"2020","journal-title":"Hypertens Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/a-1325-0381","article-title":"Diabetes mellitus and hypertension as major risk factors of mortality from COVID-19 pneumonia","volume":"130","author":"Petrakis","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/oby.22946","article-title":"The association of obesity, type 2 diabetes, and hypertension with severe coronavirus disease 2019 on admission among Mexican patients","volume":"28","author":"Denova-Gutierrez","year":"2020","journal-title":"Obesity (Silver Spring)."},{"key":"B62","doi-asserted-by":"publisher","first-page":"635623","DOI":"10.3389\/fimmu.2021.635623","article-title":"The role of B and T lymphocyte attenuator in respiratory system diseases","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/TA.0000000000003134","article-title":"Benzodiazepines increase the likelihood of both infectious and thrombotic complications","volume":"91","author":"Skicki","year":"2021","journal-title":"J Trauma Acute Care Surg."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/CCM.0b013e31827c0c8d","article-title":"Benzodiazepine augmented gamma-amino-butyric acid signaling increases mortality from pneumonia in mice","volume":"41","author":"Sanders","year":"2013","journal-title":"Crit Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40266-020-00754-1","article-title":"Psychotropic drug-associated pneumonia in older adults","volume":"37","author":"Rajamaki","year":"2020","journal-title":"Drugs Aging."},{"key":"B66","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/gps.5048","article-title":"Benzodiazepines or related drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"34","author":"Sun","year":"2019","journal-title":"Int J Geriatr Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1127262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:07:05Z","timestamp":1676394425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1127262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":66,"alternative-id":["10.3389\/fpsyt.2023.1127262"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1127262","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"article-number":"1127262"}}